• Lead: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration

  • Apr 9 2024
  • Length: 7 mins
  • Podcast
Lead: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration By cover art

Lead: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration

Listen for free

View show details

  • Summary

  • Lead Story:

    Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration

    Drug and Alcohol Dependence

    The authors studied the effect of receiving MOUD during incarceration in New York City jails on non-fatal overdose events during the year after discharge. Data were analyzed for patients with OUD incarcerated between 2011-2017 who either received MOUD during the 3 days before release (n=8660) or did not receive MOUD just prior to release (n=10,163). After controlling for covariates, those receiving MOUD had a significant reduction in non-fatal overdoses during the 14 days after release (adjusted HR: 0.49; 95% CI = 0.33-0.74). However, there was no reduction in non-fatal overdoses during the remainder of the 1 year after release. The authors speculate that this lack of benefit beyond 14 days may be due to failure to transition to outpatient MOUD after release. They conclude that MOUD in jail could be lifesaving and that it is important to ensure MOUD continues after release.

    Read this issue of the ASAM Weekly

    Subscribe to the ASAM Weekly

    Visit ASAM
    Show more Show less
Physical Illness & Disease Psychology Hygiene & Healthy Living Politics & Government
Show more Show less

What listeners say about Lead: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available